Actively Recruiting

Phase Not Applicable
Age: 18Years - 46Years
FEMALE
Healthy Volunteers
NCT06165367

Hyaluronan-enriched Medium and Euploid Blastocyst Transfers

Led by ART Fertility Clinics LLC · Updated on 2025-03-12

783

Participants Needed

1

Research Sites

102 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

It has been proposed that enriching transfer media with hyaluronan (EmbryoGlue medium) improves pregnancy outcomes compared with media containing lower concentrations of this molecule. However, none of previous studies included preimplantation genetic testing for aneuploidy (PGT-A) embryos. In order to investigate the impact of this hyaluronan-enriched on pregnancy outcomes, it is essential to evaluate its efficacy on euploid-only embryo transfers. The aim of the present study is to evaluate whether a short period of exposure of euploid blastocysts to EmbryoGlue prior to and during transfer positively impact on pregnancy outcomes of frozen embryo transfer (FET) cycles.

CONDITIONS

Official Title

Hyaluronan-enriched Medium and Euploid Blastocyst Transfers

Who Can Participate

Age: 18Years - 46Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • All frozen embryo transfer (FET) cycles with euploid blastocysts biopsied and vitrified on Day 5 after PGT-A.
  • Rank of randomization based on embryo quality.
  • Only hormonal replacement therapy (HRT) cycle regimen.
  • Women aged 18 years to 46 years.
  • Having at least 1 chromosomally normal vitrified blastocyst(s) on Day 5 available for transfer.
  • All sperm samples.
  • BMI between 18 and 35.
Not Eligible

You will not qualify if you...

  • FET cycles with preimplantation genetic testing for monogenic disorders (PGT-M) and for structural rearrangements (PGT-SR).
  • FET cycles with mosaic / aneuploid blastocysts.
  • FET cycles with unknown outcome.
  • FET cycles with Day 6 or Day 7 biopsied blastocysts.
  • FET with patients' endometrium preparation with treatments other than HRT.
  • FET where PGT-A was performed for gender selection.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

ART Fertility Clinics LLC

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 60202

Actively Recruiting

Loading map...

Research Team

D

Daniela Nogueira

CONTACT

J

Jonalyn DV Edades, Nursing

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here